Showing 1391-1400 of 2007 results for "".
- Lumenis Debuts Stellar M22™ with XPL™ at ASDS 2025, Showcases Single-Session Clearance Datahttps://modernaesthetics.com/news/lumenis-debuts-stellar-m22-with-xpl-at-asds-2025-showcases-single-session-clearance-data/2484554/Lumenis Be. Ltd. introduced the next-generation Stellar M22™ with XPL™ Technology during the 2025 Annual American Society for Dermatologic Surgery (ASDS) Meeting, highlighting single-session clearance rates of up to 100% for vascular and pigmented lesions. The multi-application aesthetic platform
- Allergan Aesthetics Celebrates Seventh Annual BOTOX® Cosmetic Dayhttps://modernaesthetics.com/news/allergan-aesthetics-celebrates-seventh-annual-botox-cosmetic-day/2484512/Allergan Aesthetics, an AbbVie company, marks the seventh annual BOTOX® Cosmetic Day on Wednesday, November 19, 2025. The yearly celebration honors patients and providers who have contributed to the longevity and success of the injectable treatment, which remains the top-selling product in its ca
- Pluri Launches Regenerative Aesthetics Subsidiary Cellav in Collaboration with Miss Universe Skincarehttps://modernaesthetics.com/news/pluri-launches-regenerative-aesthetics-subsidiary-cellav-in-collaboration-with-miss-universe-skincare/2484496/Pluri Inc. has launched Cellav Health and Aesthetics Ltd., focused on science-based regenerative skincare. The company announced a strategic collaboration with Miss Universe Skincare to co-develop a new line of cell-based skincare products.
- Beauty Rep Launches Digital Platform to Modernize Brand-Practice Collaborationhttps://modernaesthetics.com/news/beauty-rep-launches-digital-platform-to-modernize-brand-practice-collaboration/2484439/A new digital platform, Beauty Rep, has launched to streamline the way aesthetic brands and practices collaborate, aiming to reduce operational inefficiencies in sales, marketing, and education. Founded by aesthetics industry veterans, Beauty Rep provides a centralized hub for brand-practi
- AAFPRS Forecasts Regeneration, Precision, and Personalization as Defining Aesthetic Trends for 2026https://modernaesthetics.com/news/aafprs-forecasts-regeneration-precision-and-personalization-as-defining-aesthetic-trends-for-2026/2484425/Aesthetic medicine is rapidly evolving beyond enhancement and rejuvenation, moving toward regenerative, precision-driven care tailored to the individual. The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) has released its annual aesthetic trend forecast, highlighting the t
- VISTA Trial Validates Noninvasive Tool for Skin Feature Identificationhttps://modernaesthetics.com/news/vista-trial-validates-noninvasive-tool-for-skin-feature-identification/2484391/A novel imaging system may offer dermatologists a noninvasive alternative to assess histologic skin features, according to results from the VISTA Trial published in JAMA Dermatology. The multisite trial evaluated Enspectra Health’s VIO handheld cross-modal imaging system, which in
- FDA Warns Websites Selling Unapproved Botulinum Toxin Productshttps://modernaesthetics.com/news/fda-warns-websites-selling-unapproved-botulinum-toxin-products/2484341/The US Food and Drug Administration (FDA) has issued 18 warning letters to website operators illegally marketing unapproved and misbranded botulinum toxin products for cosmetic and medical use. The enforcement action follows reports of adverse events, including sym
- FDA Clears Ultherapy PRIME for Skin Laxity on Arms, Abdomenhttps://modernaesthetics.com/news/fda-clears-ultherapy-prime-for-skin-laxity-on-arms-abdomen/2484325/The US Food and Drug Administration (FDA) has cleared Ultherapy PRIME for the treatment of skin laxity on the anterior arms, posterior arms, and abdomen, according to Merz Aesthetics. The device is now FDA-cleared for noninvasive lifting and firming of the face, neck, décolleté, and body.
- FDA Approves Restylane Lyft for Chin Augmentation in Adultshttps://modernaesthetics.com/news/fda-approves-restylane-lyft-for-chin-augmentation-in-adults/2484326/Galderma announced today that the U.S. Food and Drug Administration (FDA) has approved Restylane® Lyft™ with Lidocaine for chin augmentation in adults over 21 with mild-to-moderate chin retrusion.
- Beauty Rep Launches Digital Platform to Modernize Brand-Practice Collaborationhttps://modernaesthetics.com/news/beauty-rep-launches-digital-platform-to-modernize-brand-practice-collaboration/2484323/A new digital platform, Beauty Rep, has launched to streamline the way aesthetic brands and practices collaborate, aiming to reduce operational inefficiencies in sales, marketing, and education. Founded by aesthetics industry veterans, Beauty Rep provides a centralized hub for brand-practi